Stoke Therapeutics, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Related People
Fund Service Providers
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Stoke Therapeutics, Inc.
CIK #0001623526
EDGAR Form CIK 2011 - 2026
10-K [0001623526]
10-Q [0001623526]
3 [0001623526]
4 [0001623526]
8-K [0001623526]
D [0001623526]
SC 13D [0001623526]
SC 13G [0001623526]
Form 13D/13G Filer Form 13D/13G Subject Filed
Wellington Management Group LLP Stoke Therapeutics Inc [2026-05-15]
Toronto Dominion Bank Stoke Therapeutics Inc [2025-11-14]
FMR LLC Stoke Therapeutics Inc [2025-06-06]
BlackRock Portfolio Management LLC Stoke Therapeutics Inc [2025-04-15]
Baker Bros Advisors LP Stoke Therapeutics Inc [2024-11-14]
BlackRock Inc Stoke Therapeutics Inc [2024-07-08]
Cowen Financial Products LLC Stoke Therapeutics Inc [2024-02-26]
Lynx1 Capital Management LP Stoke Therapeutics Inc [2023-11-06]
Morgan Stanley Stoke Therapeutics Inc [2023-02-10]
Vanguard Group Inc Stoke Therapeutics Inc [2022-02-10]
View All
Form 3/4/5 Subject 2011 - 2026
Stoke Therapeutics, Inc.
Ticho Barry
Allan Jonathan
Smith Julie
Krainer Adrian R.
Kaye Edward M. MD
Levin Arthur A
Tzianabos Arthur
Harrison Seth Loring
Burstein Jennifer
View All
Terms | Privacy | Providers | Guide
tony@aum13f.com